Tetanus vaccination and risk of multiple sclerosis - A systematic review

被引:34
作者
Hernan, Miguel A. [1 ]
Alonso, Alvaro [1 ]
Hernandez-Diaz, Sonia [1 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
关键词
D O I
10.1212/01.wnl.0000225079.51201.f9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To conduct a systematic review on the association between tetanus vaccination and the risk of multiple sclerosis ( MS). Methods: The authors searched the databases Medline, LILACS, EMBASE, and Science Citation Index including the period 1966 to September 1, 2005. Eligible studies had to meet the following inclusion criteria: presentation of original data, case-control or cohort design, physician-confirmed diagnosis of MS as the outcome of interest, attempt to ascertain vaccinations in a period before the diagnosis, and report of an association measure between tetanus vaccination and incidence of MS, and its 95% CI or enough information to compute it. Study specific log ORs were weighted by the inverse of their variances to obtain a pooled estimate and its 95% CI. Results: The OR of MS associated with history of tetanus vaccination was 0.67 ( 95% CI: 0.55 to 0.81). There was little indication of heterogeneity of results across studies. Conclusion: Tetanus vaccination is associated with a lower risk of multiple sclerosis.
引用
收藏
页码:212 / 215
页数:4
相关论文
共 21 条
  • [1] CLINICAL EVALUATION OF POSSIBLE ETIOLOGIC FACTORS IN MULTIPLE SCLEROSIS
    ALTER, M
    SPEER, J
    [J]. NEUROLOGY, 1968, 18 (02) : 109 - &
  • [2] Multiple sclerosis in India: A case-control study of environmental exposures
    Bansil, S
    Singhal, BS
    Ahuja, GK
    Riise, T
    Ladiwala, U
    Behari, M
    Cook, SD
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1997, 95 (02): : 90 - 95
  • [3] A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis
    Bourdette, DN
    Edmonds, E
    Smith, C
    Bowen, JD
    Guttmann, CRG
    Nagy, ZP
    Simon, J
    Whitham, R
    Lovera, J
    Yadav, V
    Mass, M
    Spencer, L
    Culbertson, N
    Bartholomew, RM
    Theofan, G
    Milano, J
    Offner, H
    Vandenbark, AA
    [J]. MULTIPLE SCLEROSIS, 2005, 11 (05): : 552 - 561
  • [4] ENVIRONMENTAL RISK-FACTORS AND MULTIPLE-SCLEROSIS - A COMMUNITY-BASED, CASE-CONTROL STUDY IN THE PROVINCE OF FERRARA, ITALY
    CASETTA, I
    GRANIERI, E
    MALAGU, S
    TOLA, MR
    PAOLINO, E
    CANIATTI, LM
    GOVONI, V
    MONETTI, VC
    FAINARDI, E
    [J]. NEUROEPIDEMIOLOGY, 1994, 13 (03) : 120 - 128
  • [5] Enhanced immunogenicity of hepatitis B surface antigen by insertion of a helper T cell epitope from tetanus toxoid
    Chengalvala, MV
    Bhat, RA
    Bhat, BM
    Vernon, SK
    Lubeck, MD
    [J]. VACCINE, 1999, 17 (9-10) : 1035 - 1041
  • [6] VIRAL-INFECTION IN PATIENTS WITH MULTIPLE-SCLEROSIS AND HLA-DR MATCHED CONTROLS
    COMPSTON, DAS
    VAKARELIS, BN
    PAUL, E
    MCDONALD, WI
    BATCHELOR, JR
    MIMS, CA
    [J]. BRAIN, 1986, 109 : 325 - 344
  • [7] Vaccinations and the risk of relapse in multiple sclerosis
    Confavreux, C
    Suissa, S
    Saddier, P
    Bourdés, V
    Vukusic, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (05) : 319 - 326
  • [8] Vaccinations and risk of central nervous system demyelinating diseases in adults
    DeStefano, F
    Verstraeten, T
    Jackson, LA
    Okoro, CA
    Benson, P
    Black, SB
    Shinefield, HR
    Mullooly, JP
    Likosky, W
    Chen, RT
    [J]. ARCHIVES OF NEUROLOGY, 2003, 60 (04) : 504 - 509
  • [9] USE OF PRIOR VACCINATIONS FOR THE DEVELOPMENT OF NEW VACCINES
    ETLINGER, HM
    GILLESSEN, D
    LAHM, HW
    MATILE, H
    SCHONFELD, HJ
    TRZECIAK, A
    [J]. SCIENCE, 1990, 249 (4967) : 423 - 425
  • [10] Recombinant hepatitis B vaccine and the risk of multiple sclerosis -: A prospective study
    Hernán, MA
    Jick, SS
    Olek, MJ
    Jick, H
    [J]. NEUROLOGY, 2004, 63 (05) : 838 - 842